# ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer

> **NCT05182866** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Rakuten Medical, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Head and Neck Cancer
- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **COMBINATION_PRODUCT:** ASP-1929 Photoimmunotherapy

## Key facts

- **NCT ID:** NCT05182866
- **Lead sponsor:** Rakuten Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-21
- **Primary completion:** 2024-07-11
- **Final completion:** 2026-06-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2024-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05182866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05182866, "ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05182866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*